Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PINS vs GSK✓SelectedUSD · GSKPINS vs GSK performance historyLatest closeAs of-1.90%11/17
Stock and ETF performance explorer

PINS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-25.9%
GSK return
+73.2%
Excess return
-99.1%
Maximum drawdown
-82.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%-2.3%+0.4%-1.1%
7D-4.6%-3.0%-1.6%-3.6%
30D-17.5%+0.4%-17.9%-17.7%
3M-21.7%-1.2%-20.5%-21.5%
6M-7.2%+0.9%-8.1%-8.1%
YTD-30.2%+4.0%-34.2%-33.0%
1Y-29.2%+7.3%-36.5%-33.0%
3Y-42.6%+57.1%-99.7%-56.8%
5Y-61.9%+43.0%-104.9%-70.5%
All-25.9%+73.2%-99.1%-47.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling